KAREN A DAWES Insider Trading for May 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KAREN A DAWES.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of KAREN A DAWES for May 2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 140.29 | 182 | 25,533 | 119,439 | 119.6 K to 119.4 K (-0.15 %) |
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 139.40 | 282 | 39,311 | 119,621 | 119.9 K to 119.6 K (-0.24 %) |
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 136.98 | 43 | 5,890 | 119,903 | 119.9 K to 119.9 K (-0.04 %) |
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 135.91 | 10 | 1,359 | 119,946 | 120 K to 119.9 K (-0.01 %) |
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 140.29 | 182 | 25,533 | 119,439 | 119.6 K to 119.4 K (-0.15 %) |
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 139.40 | 282 | 39,311 | 119,621 | 119.9 K to 119.6 K (-0.24 %) |
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 136.98 | 43 | 5,890 | 119,903 | 119.9 K to 119.9 K (-0.04 %) |
May 21 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 135.91 | 10 | 1,359 | 119,946 | 120 K to 119.9 K (-0.01 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Option Exercise | A | 128.18 | 1,761 | 225,725 | 1,761 | |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 142.45 | 80 | 11,396 | 119,956 | 120 K to 120 K (-0.07 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 141.45 | 77 | 10,892 | 120,036 | 120.1 K to 120 K (-0.06 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 140.62 | 180 | 25,312 | 120,113 | 120.3 K to 120.1 K (-0.15 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 139.32 | 122 | 16,997 | 120,293 | 120.4 K to 120.3 K (-0.10 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 138.60 | 269 | 37,283 | 120,415 | 120.7 K to 120.4 K (-0.22 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 136.92 | 160 | 21,907 | 120,684 | 120.8 K to 120.7 K (-0.13 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Sell | S | 135.76 | 712 | 96,661 | 120,844 | 121.6 K to 120.8 K (-0.59 %) |
May 19 2020 | RGEN | REPLIGEN CORP | DAWES KAREN A | Director | Grant | A | 0.00 | 722 | 0 | 121,556 | 120.8 K to 121.6 K (+0.60 %) |
May 11 2020 | DMI | Assertio Therapeut ... | DAWES KAREN A | Director | Sell | S | 0.79 | 15,834 | 12,531 | 84,589 | 100.4 K to 84.6 K (-15.77 %) |